CLNN - Clene Inc Uzoq muddatli majburiyatlarning kapitalga nisbati

Clene (CLNN) tovar belgisi

Uzoq muddatli qarzdorlikning kapitalga nisbati Clene Inc. (CLNN) moliyaviy barqarorligini ko'rsatadi, bunda ko'rsatkich 0.00 darajasida turibdi. Neyroterapiyaga bo'lgan talab iqtisodiy sikllardan mustaqil qolmoqda, bu esa biznes barqarorligini ta'minlaydi. O'sish FDA ning qat'iy nazorati va noyob patentlar bilan cheklangan; shunga qaramay, tajribali rahbariyat aktivlar sertifikatsiyasiga e'tibor qaratmoqda va yirik investorlarning ishonchini saqlab qolmoqda.

CLNN - clene.com Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022 - 28.10.2026 oraligʻida

Clene Inc (CLNN) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Clene Nanomedicine|CLNN - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Clene Inc.|CLNN - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Clene|CLNN - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati clene.com|CLNN - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Clene Inc.|CLNN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Clene Nanomedicine|CLNN - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Clene Inc.|CLNN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Clene
Kompaniyaning har tomonlama tahlili:CLNN, clene.com
Clene Inc. asosiy tovari

Kapital tuzilmasini tahlil qilish bozor tebranishlarini haqiqiy moliyaviy barqarorlikdan ajratish imkonini beradi. Ushbu ko'rsatkich kapitalga nisbatan muddati bir yildan ortiq bo'lgan majburiyatlarning ulushini o'lchaydi. Uzoq muddatli qarzlarning kapitalga nisbati ko'rsatkichini tekshirish orqali investor kredit riskining darajasini baholaydi. Clene Inc. (CLNN) uchun bu nevrologik patologiyalar uchun nanoterapiyani moliyalashtirishda juda muhimdir. ALS davolash bo'yicha ishlanmalarni diversifikatsiya qilish haddan tashqari qarzlarsiz barqaror asosni talab qiladi.

Clene Inc. kimlar bilan raqobatlashadi

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati DNLI|Uzoq muddatli qarzning o'z kapitaliga nisbati HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Amylyx Pharmaceuticals Inc (AMLX)|TRVI: Uzoq muddatli qarzning kapitalga nisbati|Praxis Corp - Uzoq muddatli majburiyatlarning kapitalga nisbati|Anavex Life Sciences (AVXL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CBLL - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati PRTA|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector|ANNX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Omeros Corp.|NGNE (Neurogene Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ACIU (acimmune.com)|VYGR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Neumora NMRA|SCLX: Uzoq muddatli qarzning kapitalga nisbati|Tevogen Bio Inc. (TVGN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|alphacognition.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com (CGTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati IKT|Uzoq muddatli qarzning o'z kapitaliga nisbati SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|Uzoq muddatli qarzning o'z kapitaliga nisbati COYA (coyatherapeutics.com)|VTGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Ovid Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Acumen Pharmaceuticals, Inc. (ABOS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati alteritytherapeutics.com|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati JUNS (Jupiter Neurosciences Inc)|Uzoq muddatli majburiyatlarning kapitalga nisbati relmada.com (RLMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS|Uzoq muddatli qarzning kapitalga nisbati GRCE (gracetx.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience Inc|ANEW Medical - Uzoq muddatli qarzning kapitalga koeffitsiyenti|NRSN (NeuroSense Therapeutics, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH - Uzoq muddatli majburiyatlarning kapitalga nisbati|MTVA (metaviatx.com) - Uzoq muddatli qarzning kapitalga nisbati|NRXS (NeurAxis Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp|Neuphoria Therapeutics Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NERV (minervaneurosciences.com)|ATHA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Addex Therapeutics Ltd. ADXN|ALZN (Alzamend) - Uzoq muddatli qarzning kapitalga nisbati|Cyclerion Therapeutics (CYCN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati protagenic.com PTIX|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CRGT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Cara Therapeutics Inc (CARA)|Chromocell Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ITCI (Intra-Cellular)|LBPH - Uzoq muddatli qarzdorlikning kapitalga nisbati|MRNS (Marinus) - Uzoq muddatli qarzning kapitalga nisbati|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli qarzning o'z kapitaliga nisbati SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix SNPX|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TRVN (Trevena Inc.)|VIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Anew Medical Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Cerevel Therapeutics (CERE) - Uzoq muddatli qarzning o'z kapitaliga nisbati